Why UiPath Stock Is a Risky Buy

UiPaths stock, PATH, has plummeted nearly 40% in six months, now at $10.11 per share. Despite potential for a bargain, analysts advise selling due to slowing revenue growth (11% annualized), stagnant billings (7.4% YoY growth), and grim revenue forecasts (9.1% growth in next 12 months). PATHs P/S ratio is reasonable, but weak fundamentals pose significant risk. Consider investing in a top endpoint security play instead. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/86a6f387d3332aad